Daiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Down – Here’s Why

Shares of Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY) gapped down before the market opened on Wednesday . The stock had previously closed at $22.33, but opened at $21.6960. Daiichi Sankyo shares last traded at $21.4050, with a volume of 56,682 shares traded.

Wall Street Analyst Weigh In

Separately, Zacks Research lowered shares of Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 19th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Daiichi Sankyo Stock Down 2.9%

The stock has a fifty day moving average price of $22.32 and a 200-day moving average price of $23.67. The firm has a market cap of $39.63 billion and a PE ratio of 20.33. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.60 and a current ratio of 2.31.

About Daiichi Sankyo

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.